Paul-Ehrlich-Institut品牌介绍

浏览量：1914

Paul-Ehrlich-Institut

品牌简介

联邦疫苗和生物医学研究所保罗-埃利希研究所(PEI)负责下列医药产品(根据《德国药品法》第77条):
人用药品
血清
疫苗
血的准备工作
组织及组织准备
过敏原
高级治疗药品(基因治疗、体细胞治疗和生物技术操纵组织产品)
异种药品
基因工程血液成分。
联邦药品和医疗器械研究所(Bundesinstitut f<e:1> r Arzneimittel und medizinproduckte, BfArM)是所有其他药品的主管机构。

The Paul-Ehrlich-Institut (PEI), Federal Institute for Vaccines and Biomedicines is responsible for the medicinal products listed below (pursuant to Section 77 AMG [Arzneimittelgesetz, German Medicines Act]):

Human Medicinal Products

Sera

Vaccines

Blood preparations

Tissues and tissue preparations

Allergens

Advanced therapy medicinal products (gene therapeutics, somatic cell therapeutics, and biotechnogically manipulated tissue products)

Xenogenic medicinal products

Genetically engineered blood components.

The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) is the competent authority for all other medicinal products.

Main product